A Study of Orelabrutinib in CLL/SLL Patients Who Are Slowly Responding to Ibrutinib
Clinical trial NCT05491044 · UNKNOWN
Trial details
- NCT number
- NCT05491044
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2024-08-28
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.